Idexx Laboratories IDXX
NASDAQ IDXX
$676.04 +5.33 (+0.79%)
At close: Nov 6, 2026 · 4:00 PM EST

Idexx Laboratories (IDXX) Non Operating Interest Expenses (2009 - 2026)

Updated

Idexx Laboratories (IDXX) posted Non Operating Interest Expenses of $7.46 million for Q3 2026, down 30.0% from $10.66 million a year earlier and down 26.7% from the prior quarter.

Analysis

Idexx Laboratories (IDXX) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Non Operating Interest Expenses at Idexx Laboratories was $34.59 million, down 6.9% year-over-year; for FY2025, it came in at $38.85 million, up 24.5% from FY2024.

  • Annual Non Operating Interest Expenses shows a five-year compound annual growth rate of 3.2% (FY2020 to FY2025).
  • In prior years, Idexx Laboratories' Non Operating Interest Expenses was $31.21 million in FY2024 (-25.0%), $41.58 million in FY2023 (+4.3%), $39.86 million in FY2022 (+33.7%) and $29.81 million in FY2021 (-10.0%).
  • The Q3 2026 figure stands as the lowest quarterly Non Operating Interest Expenses since Q1 2022.
  • On a year-over-year basis, Non Operating Interest Expenses increased in four of the last eight quarters, with growth averaging 5.0%.
  • The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q1 2023, with growth of 87.6%; the weakest was Q1 2024, with a decline of 39.7%.
  • According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $10.18 million (Q2 2026), $7.74 million (Q1 2026) and $9.21 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn -
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 217.00 Mn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn -
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn -
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -477.00 Mn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 269.00 Mn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn -
10 Idexx Laboratories 53.33 Bn 52.56 Bn 764.30 Mn 7.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 7.46 Mn
Jun 30, 2026 10.18 Mn
Mar 31, 2026 7.74 Mn
Dec 31, 2025 9.21 Mn
Sep 30, 2025 10.66 Mn
Jun 30, 2025 11.32 Mn
Mar 31, 2025 7.67 Mn
Dec 31, 2024 7.50 Mn
Sep 30, 2024 7.70 Mn
Jun 30, 2024 8.10 Mn
Mar 31, 2024 7.91 Mn
Dec 31, 2023 9.27 Mn
Sep 30, 2023 8.65 Mn
Jun 30, 2023 10.54 Mn
Mar 31, 2023 13.13 Mn
Dec 31, 2022 13.55 Mn
Sep 30, 2022 11.00 Mn
Jun 30, 2022 8.32 Mn
Mar 31, 2022 7.00 Mn
Dec 31, 2021 7.48 Mn
API Access

Idexx Laboratories Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=IDXX&period=max&api_key=YOUR_API_KEY